Amazon Appoints Telehealth Veteran to Lead Healthcare Unit Amid Expansion Efforts Nifty IT May Be Bottoming Out Says Geojits Anand James Pharma ProfitBooking and Two Potential ShortTerm Plays South KoreaNetherlands Chip Alliance Expands Beyond ASML Semiconductor Partnership Anthony Edwards Capitalizes on Adidas Partnership to Boost Commercial Growth Microsoft and Anthropic in Advanced Talks for Maia AI Chip Supply Deal After 5 Billion Investment Intuits Latest Earnings Results Test Morgan Stanleys Stock Projection CEG Q1 2026 Earnings EPS Beats Estimates as Constellation Capitalizes on Nuclear and Clean Energy Demand BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat LSPD Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Execution Progress INFU Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Slides Lower Porch Group Q1 2026 Earnings Loss Narrower Than Expected Stock Edges Higher AVAH Q1 2026 Earnings Strong EPS Beat Masks Market Concerns 707 Cayman Holdings JEM Holds Steady at 150 Consolidation Phase Signals Caution Candel Therapeutics CADL Attempts Recovery as Stock Nears Resistance Oculis Holding OCS Dips 487 Key Support Levels in Focus After Sharp Decline PennyMac Mortgage Investment Trust 900 Senior Notes PMTW Hold Steady Near Par Technical and Fundamental Outlook WF Holding WFF Surges 117 Breaking Through Resistance or Temporary Rally Arabica Coffee Prices Soar to Record High Amid USColombia Tariff Dispute CBFV Q1 2026 Earnings EPS Beats Estimates Stock Rises on Strong Performance Oatly OTLY Holds Steady Near Support as PlantBased Sector Faces Headwinds Aviat Networks AVNW Holds Near Support as Trading Range Narrows Logistic Properties of the Americas LPA Holds Steady Near Support What Investors Should Know WiMi Hologram Cloud Slips Amid Subdued Trading Key Support in Focus Veru Inc Holds Steady Near Support Amid Low Volatility LZ Technology Holdings LZMH Surges 85 as Bullish Momentum Builds Near Resistance EquipmentSharecom Inc EQPT Gains Momentum Shares Climb 56 on Strong Volume Neumora Therapeutics NMRA Edges Lower as Stock Tests Key Support at 175